Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00268229
Status:
COMPLETED
Last Update Posted:
2013-02-15
First Post:
2005-12-20
Brief Title:
Imatinib Mesylate Daunorubicin and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Sponsor:
The Cleveland Clinic
Organization:
The Cleveland Clinic
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07
Start Date Type:
None
Primary Completion Date:
2011-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-08
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-20
First Submit QC Date:
December 20 2005
Study First Post Date:
2005-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-02-12
Last Update Post Date:
2013-02-15
Last Update Post Date Type:
ESTIMATED